Financial figures

Overview of DSM's latest financial key figures

Overview as at Q3 2019

Presented below are DSM's net sales from continuing operations, adjusted net earnings per ordinary share, balance sheet, income statement and finally, cash flow statement, as at Q3 2019.

Net sales (continuing operations) in € million

Year Q1 Q2 Q3 Q4 Total
2019 2,292 2,276 2,290    
2018 2,435 2,359 2,265 2,208 9,267
2017 2,159 2,161 2,136 2,176 8,632
2016 1,913 1,994 1,998 2,015 7,920
2015 1,886 1,754 2,102 1,926 7,722
2014 2,298 2,288 2,323 2,175 9,181
2013 2,376 2,468 2,397 2,377 9,618
2012 2,290 2,268 2,304 2,269 9,131
2011 2,234 2,265 2,322 2,227 9,048
2010 1,933 2,120 2,041 2,082 8,176
2009 1,578 1,664 1,725 1,758 6,725
2008 2,303 2,406 2,336 2,034 9,079

Adjusted net earnings per ordinary share (continuing operations)

Year Q1 Q2 Q3 Q4 Total
2019 1.12 1.20 1.36    
2018 1.91 1.73 1.18 1.02 5.84
2017 0.92 0.98 0.91 1.11 3.92
2016 0.60 0.76 0.81 0.73 2.90
2015 0.39 0.63 0.59 0.53 2.14
2014 0.57 0.64 0.69 0.52 2.42
2013 0.70 0.79 0.76 0.58 2.84
2012 0.87 0.67 0.61 0.43 2.58
2011 0.91 0.97 0.94 0.71 3.53
2010 0.70 0.92 0.76 0.63 2.89
2009 0.05 0.22 0.53 0.56 1.44
2008 0.81 1.00 0.97 0.25 3.04

Balance sheet

Assets in € million 30 Sep 2019 Year-end 2018
Intangible Assets 3,430 3,090
Property, Plant & Equipment 3,932 3,511
Deferred Tax Assets 192 248
Share in Associates & Joint Ventures 159 205
Financial derivatives 11 14
Other Financial Assets 296 263
Non-Current Assets 8,020 7,331
Inventories 2,118 1,993
Trade Receivables 1,719 1,575
Income tax receivables 85 83
Other Current Receivables 60 80
Financial Derivatives 31 21
Current Investments 853 1,277
Cash & Cash Equivalents 926 1,281
Current Assets 5,792 6,310
Total Assets 13,812 13,641
Equity & Liabilities in € million 30 Sep 2019 Year-end 2018
Shareholders' Equity 8,063 7,782
Non-controlling interest 99 33
Equity 8,162 7,815
Deferred Tax Liabilities 270 254
Employee Benefits Liabilities 451 413
Provisions 109 116
Borrowings 2,459 2,272
Financial derivatives 11 3
Other Non-current Liabilities 143 197
Non-current liabilities 3,443 3,255
Employee Benefits 46 46
Provisions 36 37
Borrowings 126 380
Financial Derivatives 77 51
Trade Payables 1,365 1,430
Income tax payable 91 100
Other Current Liabilities 466 527
Current Liabilities 2,207 2,571
Total Equity and Liabilities 13,812 13,641

Income statement

Condensed consolidated statement of income Q3 2019

In € million Jan - Sep 2019 Jan - Sep 2018
Sales 6,858 7,059
EBITDA 1,239 1,414
Operating profit (EBIT) 784 1,049
Financial income and expense -81 -75
Profit before income tax expense 703 974
Income tax expense -122 -171
Share of the profit of associates /joint control entities 59 18
Net profit 640 821
Of which:    
Profit attributable to non-controlling interests -5 -2
Net profit attributable to equity holders of DSM 635 819
Dividend on cumulative preference shares -6 -6
Net profit available to holders of ordinary shares 629 813
Depreciation and amortization 455 365

Reconciliation to Alternative Performance Measures H1 2019

In € million Jan - Sep 2019 Jan - Sep 2018
EBITDA 1,239 1,414
Acquisitions/divestments  8 -12
Restructuring  41 51
Other 0 -1
Sub-total APM adjustments to EBITDA 49 38
Adjusted EBITDA 1,288 1,452
Operating profit (EBIT) 784 1,049
APM adjustments to EBITDA 49 38
Impairments of PPE and Intangible assets 11 13
Sub-total APM adjustments to operating profit (EBIT) 60 51
Adjusted operating profit (EBIT) 844 1,100
Net profit 640 821
APM adjustments to operating profit (EBIT) 60 51
APM adjustments to financial income and expense   0
Income tax related to APM adjustments -15 -14
APM adjustments to share of the profit of associates /joint control entities -26 -6
Sub-total APM adjustments to net profit  19 31
Adjusted net profit 659 852
     
Net profit available to holders of ordinary shares 629 813
APM adjustments to net profit 19 31
Adjusted net profit available to holders of ordinary shares 648 844

Cash flow statement

Assets in € million Jan - Sep 2019 Jan - Sep 2018
Cash, Cash Equivalents and Current Investments (at beginning of period) 2,558 1,853
Current Investments (at beginning of period) 1,277 954
Cash & Cash Equivalents (at beginning of period) 1,281 899
     
Operating Activities    
EBITDA 1,239 1,414
Change in Working  Capital -207 -448
Income Tax -67 -59
Other -24 26
Cash provided by Operating Activities (Operating cash flow) 941 933
     
Investing Activities    
Capital Expenditures -420 -470
Payments regarding drawing rights -8 -18
Acquisitions -411 -10
Disposal of Subsidiaries, Businesses & Associates 16 27
Disposal of Other Non-current Assets 4 13
Change in Fixed-term Deposits 424 -46
Interest Received 7 16
Dividend and capital (re)payments  12 -41
Other 12 24
Cash used in Investing Activities -364 -505
Dividend -277 -223
Interest Paid  -52 -39
Repurchase of shares -448 -213
Proceeds from re-issued treasury shares 164 91
Proceeds from / repayment of corporate bonds -300  
Payment of lease liabilities -40 0
Other Cash from/ used in Financing Activities 12 48
Cash from / used in Financing Activities -941 -336
Exchange Differences 9 6
Cash and Cash Equivalents (end of period) 926 997
Current Investment (end of period)  853 1,001
Cash and Cash Equivalents & Current Investments (end of period) 1,779 1,998

Read more

  • Share center

    DSM's ordinary shares, share performance, share listings, share structure, cumulative preference shares and shareholder base.

This site uses cookies to store information on your computer.

Learn more